This is the authors' abstract. We don't add key points for this paper.
The isolated, perfused rat mesenteric bed releases a cytochrome P450-linked metabolite of arachidonic acid (AA) as endothelium-derived hyperpolarizing factor (EDHF) in response to acetylcholine and histamine. This study assessed the relative contribution of two AA-generating pathways, phospholipase A₂ (PLA₂) and diacylglycerol (DAG) lipase, to EDHF-mediated dilation of the rat mesenteric bed. We tested the hypothesis that PLA₂-mediated release of AA is essential for the production of EDHF. Mesenteric beds were perfused with physiological salt solution (PSS) containing indomethacin and nitro-L-arginine methyl ester to block cyclooxygenase and nitric oxide synthase, respectively, and constricted with cirazoline (an α₁-adrenoceptor agonist). Bolus applications of acetylcholine and histamine caused dose-dependent dilation of the constricted beds. The 85-kDa PLA₂ inhibitor, arachidonyl trifluoromethyl ketone (AACOCF₃), at 3 µM, profoundly blunted decreases in perfusion pressure initiated by 1 nmol acetylcholine (94.3 ± 1.7%) and by 100 nmol histamine (88.5 ± 3.3%) to 9.6 ± 7.5 and 8.6 ± 6.0%, respectively. AACOCF₃ also blocked cirazoline-stimulated release of 6-keto-PG1α, but did not alter the vasodilation initiated by sodium nitroprusside (a nitric oxide donor), cromakalim (a K⁺ channel activator), or by Na⁺/K⁺-ATPase activation, as measured by KCl vasodilation in preconstricted beds perfused with K⁺-free PSS. The 14-kDa PLA₂ inhibitor, oleyloxyethyl phosphorylcholine, also blocked EDHF vasodilation and also significantly inhibited K⁺ channel activity. Neither the Ca²⁺-independent PLA₂ inhibitor, HELSS [E-6-(bromomethylene)-tetrahydro-3-(1-naphthalenyl)-2H-pyran-2-one], nor DAG lipase inhibitor, RHC-80267 [1,6-bis-(cyclohexyloximino-carbonylamino)-hexane] altered EDHF-mediated vasodilation. However, RHC-80267 blocked cirazoline-stimulated release of 6-keto-PGF1α. We conclude that Ca²⁺-dependent PLA₂, rather than DAG lipase, generates the AA for the production of EDHF in the perfused rat mesenteric bed.
No takes yet. Share an insight, caveat, or question.
Adeagbo et al. (1998) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: